Gain Therapeutics's market cap is currently $62.55M. The company's EPS TTM is $-0.19; its P/E ratio is ―; Gain Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
